GSK nelle notizie
Unire scienza tecnologia talento
Tamtam ha trovato 20 articoli recenti su GSK.
- GSK (LSE:GSK) Adds A New Hepatology Candidate, Is The 18% Undervaluation Case Intact?
- GSK plc : Berenberg remains its Buy rating
- GSK: The Gas Pedal Is Finally Down (NYSE:GSK)
- Can HUTCHMED (LSE:HCM) turn its FTSE 100 partner GSK into clinical momentum after dosing a first patient?
- REG - GSK PLC - Admission to Trading
- 19,352 GSK (GSK) shares join London trading under its Share Save Plan 2022.
- GSK-owned ViiV succeeds in late-stage trial for HIV therapy
- Why Is GSK (LSE:GSK) Stock Back In Focus This Week After The Nuvalent Agreement?
- GSK Announces Admission of 19,352 Shares Under Share Save Plan to London Stock Exchange
- Avalere Health names GSK alum Wendy Jory, Ph.D. as senior VP, market access
- AN2 Therapeutics Secures Extended Gates Foundation Funding For GSK Tuberculosis Collaboration
- GSK stock reports Q2 sales growth despite profit hit
- Can FTSE 100 Drugmaker (LSE:GSK) Turn Its Nuvalent Acquisition Into A Fresh Growth Engine After This Week's Deal News?
- GSK’s Regional President Mike Crichton on leading winning teams from Singapore
- GSK agrees to acquire myeloma therapy. GSK stock costs EUR 20.83
- GSK agrees to acquire ChImagen therapy: what it means for GSK stock at $750 million
- GSK | 10/2/26
- GSK Sports and Social Club vows to fight closure
- How Is GSK (LSE:GSK) Stock Reacting This Week To Its Wave Life Sciences Liver Candidate?
- GSK (LSE:GSK) Gets Extended Gates Funding For Tuberculosis Drug Research
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come GSK?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili